Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors
Akash J. Patel, Ying-Wooi Wan, Rami Al‐Ouran, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 43, pp. 21715-21726
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

A molecularly integrated grade for meningioma
Joseph Driver, Samantha E. Hoffman, Sherwin Tavakol, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 5, pp. 796-808
Open Access | Times Cited: 146
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
William Chen, Abrar Choudhury, Mark W. Youngblood, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3067-3076
Open Access | Times Cited: 54
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 28
Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma
Stephen T. Magill, Harish N. Vasudevan, Kyounghee Seo, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 75
Molecular alterations in meningioma: prognostic and therapeutic perspectives
Cristina Birzu, Matthieu Peyre, Felix Sahm
Current Opinion in Oncology (2020) Vol. 32, Iss. 6, pp. 613-622
Closed Access | Times Cited: 72
Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies
James C. Bayley, Caroline Hadley, Arif Harmanci, et al.
Science Advances (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 62
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Abrar Choudhury, William Chen, Calixto‐Hope G. Lucas, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 3, pp. 520-530
Open Access | Times Cited: 40
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice
Frank Szulzewsky, Sonali Arora, Aleena Arakaki, et al.
Genes & Development (2022) Vol. 36, Iss. 13-14, pp. 857-870
Open Access | Times Cited: 39
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto‐Hope G. Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Nature Genetics (2024) Vol. 56, Iss. 6, pp. 1121-1133
Open Access | Times Cited: 15
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 2, pp. 319-330
Open Access | Times Cited: 12
The Role of Merlin/NF2 Loss in Meningioma Biology
Sung‐Ho Lee, Patrick J. Karas, Caroline Hadley, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1633-1633
Open Access | Times Cited: 71
WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
Alexander F. Haddad, Jacob S. Young, Ishan Kanungo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63
Radiotherapy for meningiomas
William Chen, Haley K. Perlow, Abrar Choudhury, et al.
Journal of Neuro-Oncology (2022) Vol. 160, Iss. 2, pp. 505-515
Open Access | Times Cited: 30
Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma
Abdul Wali Khan, Collin W. English, William Chen, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 501-503
Open Access | Times Cited: 21
Genomic markers of recurrence risk in atypical meningioma following gross total resection
Rachael A. Vaubel, Rahul Kumar, Taylor M. Weiskittel, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 18
Radiotherapy and radiosurgery for meningiomas
William Chen, Calixto‐Hope G. Lucas, Stephen T. Magill, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. Supplement_1, pp. i67-i83
Open Access | Times Cited: 18
Molecular classification and grading of meningioma
MacLean P. Nasrallah, Kenneth Aldape
Journal of Neuro-Oncology (2023) Vol. 161, Iss. 2, pp. 373-381
Closed Access | Times Cited: 17
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy
Abrar Choudhury, Martha A. Cady, Calixto‐Hope G. Lucas, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1823-1837
Closed Access | Times Cited: 8
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome
H. Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Cell Genomics (2024) Vol. 4, Iss. 6, pp. 100566-100566
Open Access | Times Cited: 8
EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6
Basis for Immunotherapy for Treatment of Meningiomas
Tomás Garzón-Muvdi, Destiny D. Bailey, Mark N. Pernik, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 41
Newly established patient-derived organoid model of intracranial meningioma
Shintaro Yamazaki, Fumiharu Ohka, Masaki Hirano, et al.
Neuro-Oncology (2021) Vol. 23, Iss. 11, pp. 1936-1948
Open Access | Times Cited: 40
DREAM On: Cell Cycle Control in Development and Disease
Hayley C Walston, Audra N. Iness, Larisa Litovchick
Annual Review of Genetics (2021) Vol. 55, Iss. 1, pp. 309-329
Open Access | Times Cited: 38
The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review
Ataollah Shahbandi, Darsh S. Shah, Caroline Hadley, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 483-483
Open Access | Times Cited: 15
Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas
Naomi Zakimi, Christina Mazcko, Christine M. Toedebusch, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top